These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 17448645
1. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic. Vosahlikova S, Drevinek P, Cinek O, Pohunek P, Maixnerova M, Urbaskova P, van den Reijden TJ, Dijkshoorn L, Nemec A. Res Microbiol; 2007 May; 158(4):324-9. PubMed ID: 17448645 [Abstract] [Full Text] [Related]
2. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Bradbury R, Champion A, Reid DW. Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887 [Abstract] [Full Text] [Related]
3. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [Abstract] [Full Text] [Related]
4. Pseudomonas aeruginosa diversity in distinct paediatric patient groups. Tramper-Stranders GA, van der Ent CK, Wolfs TF, Kimpen JL, Fleer A, Johansen U, Johansen HK, Høiby N. Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596 [Abstract] [Full Text] [Related]
5. [Bacteriological monitoring of the treatment of Pseudomonas aeruginosa infections with amikacin administrated at once-daily dosis in patients with cystic fibrosis]. Canis F, Husson MO, Vic P, Ategbo S, Turck D, Courcol R, Leclerc H. Pathol Biol (Paris); 1995 Apr; 43(4):343-51. PubMed ID: 7567127 [Abstract] [Full Text] [Related]
6. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B, Repetto T, Döring G, de Martino M. J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902 [Abstract] [Full Text] [Related]
7. [Multidrug resistant clones of Pseudomonas aeruginosa in the Czech Republic]. Nemec A, Maixnerová M, Musílek M. Klin Mikrobiol Infekc Lek; 2008 Oct; 14(5):168-72. PubMed ID: 19051164 [Abstract] [Full Text] [Related]
8. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients. Nazik H, Ongen B, Erturan Z, Salcioğlu M. Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637 [Abstract] [Full Text] [Related]
9. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L. Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511 [Abstract] [Full Text] [Related]
10. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. Oie S, Uematsu T, Sawa A, Mizuno H, Tomita M, Ishida S, Okano Y, Kamiya A. J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851 [Abstract] [Full Text] [Related]
11. Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital. Bradbury RS, Champion AC, Reid DW. J Hosp Infect; 2009 Oct; 73(2):151-6. PubMed ID: 19699556 [Abstract] [Full Text] [Related]
12. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients. Ojeniyi B, Petersen US, Høiby N. APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219 [Abstract] [Full Text] [Related]
13. Molecular epidemiology of Pseudomonas aeruginosa from cystic fibrosis in Sicily: genome macrorestriction analysis and rapid PCR-ribotyping. Agodi A, Sciacca A, Campanile F, Messina C, Barchitta M, Sciacca S, Stefani S. New Microbiol; 2000 Jul; 23(3):319-27. PubMed ID: 10939047 [Abstract] [Full Text] [Related]
14. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II. Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923 [Abstract] [Full Text] [Related]
15. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey. Ojeniyi B. APMIS Suppl; 1994 Aug; 46():1-44. PubMed ID: 7811529 [Abstract] [Full Text] [Related]
16. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C. J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [Abstract] [Full Text] [Related]
17. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms. Bosso JA, Mauldin PD, Steed LL. Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687 [Abstract] [Full Text] [Related]
18. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis]. Coban AY, Ciftci A, Onuk EE, Erturan Z, Tanriverdi Cayci Y, Durupinar B. Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909 [Abstract] [Full Text] [Related]
19. Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation. Edenborough FP, Stone HR, Kelly SJ, Zadik P, Doherty CJ, Govan JR. J Cyst Fibros; 2004 Mar; 3(1):37-44. PubMed ID: 15463885 [Abstract] [Full Text] [Related]